CIK 0001411685
- Non-accelerated filer
- Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 205093315
- Phone
- +1 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-07 | Prince Joshua S. Chief Operating Officer | Grant or award · Incentive Stock Option (right to buy) | +18,752 | 18,752 | ||
| 2026-04-07 | Prince Joshua S. Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +56,248 | 56,248 | ||
| 2025-12-31 | Prince Joshua S. Chief Operating Officer | Grant or award | +4,386 | $0.56 | $2K | 15,249 |
| 2025-06-30 | Prince Joshua S. Chief Operating Officer | Grant or award | +4,882 | $1.70 | $8K | 10,863 |
| 2025-06-23 | Prince Joshua S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-12-31 | Prince Joshua S. Chief Operating Officer | Grant or award | +3,310 | $2.51 | $8K | 5,981 |
| 2024-06-28 | Prince Joshua S. Chief Operating Officer | Grant or award | +2,671 | $2.96 | $8K | 2,671 |
| 2024-06-24 | Prince Joshua S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 8 trades